BNP and NT-proBNP for Predicting Heart Complications: Prognostic Biomarker Review
Review of BNP and NT-proBNP as prognostic biomarkers confirms their predictive value for adverse cardiovascular events across multiple clinical settings.
Quick Facts
What This Study Found
Review of BNP and NT-proBNP as prognostic biomarkers confirms their predictive value for adverse cardiovascular events across multiple clinical settings.
Key Numbers
Meta-analysis of studies examining BNP and NT-proBNP as prognostic markers for adverse outcomes, cardiovascular events, and mortality in HFpEF.
How They Did This
In publication.
Why This Research Matters
Relevant to peptide therapeutics.
The Bigger Picture
Advances peptide evidence.
What This Study Doesn't Tell Us
In publication.
Questions This Raises
- ?Long-term implications?
- ?Evidence comparison?
- ?Next steps?
Trust & Context
- Key Stat:
- Key finding Review of BNP and NT-proBNP as prognostic biomarkers confirms their predictive value for adverse car
- Evidence Grade:
- Based on design.
- Study Age:
- Published in 2025.
- Original Title:
- BNP and NT-proBNP as prognostic biomarkers for the prediction of adverse outcomes in HFpEF patients: A systematic review and meta-analysis.
- Published In:
- Heart failure reviews, 30(1), 45-54 (2025)
- Authors:
- Ammar, Lama A, Massoud, Gaelle P, Chidiac, Charbel, Booz, George W, Altara, Raffaele, Zouein, Fouad A
- Database ID:
- RPEP-09931
Evidence Hierarchy
Combines results from multiple studies to find an overall pattern.
What do these levels mean? →Frequently Asked Questions
What does this mean?
Review of BNP and NT-proBNP as prognostic biomarkers confirms their predictive value for adverse cardiovascular events across multiple clinical settings.
How reliable?
Consult publication.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09931APA
Ammar, Lama A; Massoud, Gaelle P; Chidiac, Charbel; Booz, George W; Altara, Raffaele; Zouein, Fouad A. (2025). BNP and NT-proBNP as prognostic biomarkers for the prediction of adverse outcomes in HFpEF patients: A systematic review and meta-analysis.. Heart failure reviews, 30(1), 45-54. https://doi.org/10.1007/s10741-024-10442-6
MLA
Ammar, Lama A, et al. "BNP and NT-proBNP as prognostic biomarkers for the prediction of adverse outcomes in HFpEF patients: A systematic review and meta-analysis.." Heart failure reviews, 2025. https://doi.org/10.1007/s10741-024-10442-6
RethinkPeptides
RethinkPeptides Research Database. "BNP and NT-proBNP as prognostic biomarkers for the predictio..." RPEP-09931. Retrieved from https://rethinkpeptides.com/research/ammar-2025-bnp-and-ntprobnp-as
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.